# Chemotherapy Combined With Adebrelimab and Mecapegfilgrastim in Neoadjuvant Treatment of Potentially Resectable BTC

Source: https://onco.cc/trials/nct06037655/  
OnCo record `nct06037655` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of adebrelimab in gallbladder cancer and other biliary tract cancers, run by The First Affiliated Hospital with Nanjing Medical University, not yet recruiting.

## Summary

Chemotherapy Combined With Adebrelimab and Mecapegfilgrastim in Neoadjuvant Treatment of Potentially Resectable BTC is a phase 2 interventional study registered as NCT06037655 by The First Affiliated Hospital with Nanjing Medical University, with a registry enrolment figure of 30 participants, started 2023-09-25 and due to reach its primary completion in 2026-03-31. Interventions recorded: Total Neoadjuvant Treatment. Conditions listed: Biliary Tract Neoplasms. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: planned
- Last checked: 2026-09-24
- Also known as: Modified
- Tags: ctgov-ingest; gallbladder-deep-dive
- Registry id: NCT06037655
- Phase: 2
- Setting: Gemcitabine/Cisplatin Combined With Adebrelimab and Mecapegfilgrastim in Neoadjuvant Treatment of Potentially Resectable Biliary Tract Carcinoma, A Single-arm Study
- Sponsor: The First Affiliated Hospital with Nanjing Medical University
- Enrolled: 30

## Sources

- ClinicalTrials.gov NCT06037655: https://clinicaltrials.gov/study/NCT06037655

## Connected records

- cancers: [Biliary tract cancer (all types)](https://onco.cc/cancers/biliary-tract-cancer/), [Biliary tract cancer (cholangiocarcinoma)](https://onco.cc/cancers/cholangiocarcinoma/), [Gallbladder cancer](https://onco.cc/cancers/gallbladder/)
- technologies: [Immune checkpoint inhibitors](https://onco.cc/technologies/checkpoint-inhibitor/)
- drugs: [Adebrelimab](https://onco.cc/drugs/adebrelimab/)
- terms: [Gallbladder cancer in biliary tract cancer trials (eligibility and subgroups)](https://onco.cc/terms/gallbladder-cancer-in-biliary-trials/)

---
JSON: https://onco.cc/api/v1/entities/nct06037655.json